Expressive language sampling as a source of outcome measures for treatment studies in fragile X syndrome: feasibility, practice effects, test-retest reliability, and construct validity

• Type of Material: Article
• Authors: Leonard Abbeduto, University of California Davis; Elizabeth Berry-Kravis, Rush University; Audra Sterling, University of Wisconsin; Stephanie Sherman, Emory University; Jamie O. Edgin, University of Arizona; Andrea McDuffie, University of California Davis; Anne Hoffmann, Rush University; Debra Hamilton, Emory University; Michael Nelson, Rush University; Jeannie Aschkenasy, Rush University; Angela John Thurman, University of California Davis
• Language: English
• Date: 2020-03-24
• Publisher: BMC
• Publication Version: Final Published Version
• Copyright Statement: © The Author(s). 2020, corrected publication 2020.
• License: Creative Commons Attribution 4.0 International
• Final Published Version (URL): http://dx.doi.org/10.1186/s11689-020-09313-6
• Title of Journal or Parent Work: Journal of Neurodevelopmental Disorders
• Volume: 12
• Issue: 1
• Start Page: 10
• End Page: 10
• Grant/Funding Information: This research was supported by grants R01HD074346, U54HD079125, and UL1TR001860 from the National Institutes of Health.
• Keywords: Mean lenght; Cognition; treatment; FMRI; Utterance; Neurosciences; Clinical Neurology; Life Sciences & Biomedicine; Psychometrics; Clinical trials; Autism; Fragile X syndrome; Adolescents; Science & Technology; Outcome measures; Down syndrome; Children; Age; Neurosciences & Neurology; Expressive language
• Research Categories: Chemistry, Biochemistry; Health Sciences, Speech Pathology; Psychology, Behavioral; Biology, Neuroscience; Speech Communication

Abstract

Background: The evaluation of treatment efficacy for individuals with fragile X syndrome (FXS) or intellectual disability (ID) more generally has been hampered by the lack of adequate outcome measures. We evaluated expressive language sampling (ELS) as a procedure for generating outcome measures for treatment research in FXS. We addressed: (a) feasibility, (b) practice effects over two administrations, (c) test-retest reliability over the repeated administrations, and (d) construct validity. We addressed these issues for the full sample as well as for subgroups defined by age, IQ, and ASD status. Methods: Participants were 106 individuals with FXS between ages 6 and 23 years who had IQs within the range of intellectual disability (IQ < 70). ELS procedures for collecting samples in conversation and narration were followed and analyzed separately. Five measures were derived from transcripts segmented into C-units (i.e., an independent clause and its modifiers): number of C-units per minute (talkativeness), number of different word roots (vocabulary), C-unit length in morphemes (syntax), percentage of C-units containing dysfluency (utterance planning), and percentage of C-units that were fully or partly unintelligible (articulatory quality). ELS procedures were administered twice at 4-week intervals for each participant. Standardized tests and informant reports were administered and provided measures for evaluating construct validity of ELS measures. Results: We found low rates of noncompliance, suggesting the task can be completed meaningfully by most individuals with FXS, although noncompliance was higher for younger, lower IQ, and more autistic participants. Minimal practice effects and strong test-retest reliability over the 4-week interval were observed for the full sample and across the range of ages, IQs, and autism symptom severity. Evidence of convergent construct validity was observed for the measures of vocabulary, syntax, and unintelligibility for the full sample and across the range of IQ and autism symptom severity, but not for participants under age 12. Conversation and narration yielded largely similar results in all analyses. Conclusions: The findings suggest that the ELS procedures are feasible and yield measures with adequate psychometric properties for a majority of 6 to 23 years with FXS who have ID. The procedures work equally well regardless of level of ID or degree of ASD severity. The procedures, however, are more challenging and have somewhat less adequate psychometric properties for individuals with FXS under age 12.